结论：平喘合剂可降低LPO、提高SOD而治疗哮喘。
Conclusion: Pingchuan Heji could treat asthma by lowering the level of LP...
目的：探讨医院制剂益肾平喘合剂防治小鼠支气管哮喘的作用机制。
Objective: The mechanism of Yishen Pingchuan composition on prevention and cure bronchial asthma in asthmatic mice will be investigated.
目的：观察平喘合剂及普米克、氨茶碱对哮喘患者外周血细胞计数、SIL2r、IL 2的影响。
Objective To investigate effects of Pingchuan Heji, aminophylline and BUD on peripheral blood cell count, SIL 2r and IL 2 of patients suffered from cold asthma.
结果：平喘合剂治疗组与对照组综合疗效无显著差异，治疗组治疗后lpo比治疗前明显降低，SOD治疗后比治疗前显著提高。
Result: There was not obvious difference between Pingchuan Heji group and control group in the clinical curative effect, and Pingchuan Heji could enhance the level of SOD, lower the level of LPO.
结果：平喘合剂治疗组与对照组综合疗效无显著差异，治疗组治疗后lpo比治疗前明显降低，SOD治疗后比治疗前显著提高。
Result: There was not obvious difference between Pingchuan Heji group and control group in the clinical curative effect, and Pingchuan Heji could enhance the level of SOD, lower the level of LPO.
应用推荐